Open AccessCardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management
Author(s) -
Hersh Shroff,
Lisa B. VanWagner
Publication year - 2020
Publication title -
current hepatology reports
Language(s) - English
Resource type - Journals
ISSN - 2195-9595
DOI - 10.1007/s11901-020-00530-0
Subject(s) - medicine , intensive care medicine , steatohepatitis , nonalcoholic steatohepatitis , disease , metabolic syndrome , nonalcoholic fatty liver disease , steatosis , clinical trial , fatty liver , obesity
The global burden of non-alcoholic steatohepatitis (NASH) as a major cause of chronic liver disease continues to rise. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in this patient population. The current review summarizes recent advances in the understanding of CVD in NASH and strategies for screening and management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom